This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jabil, ConAgra: Premarket Trading

Stocks in this article: JBL CAG NKE DRI TD

(Premarket story updated with Jabil Circuit news and share price information.)
NEW YORK ( TheStreet) -- Jabil Circuit (JBL) beat analysts' first-quarter earnings expectations.

The electronics contract manufacturer posted earnings of $132.1 million, or 61 cents a share, for the three months ended Nov. 30, up from of $68.3 million, or 32 cents a share, a year earlier. Earnings came in ahead of the average estimate of analysts polled by Thomson Reuters for earnings of 54 cents a share.

Shares of the company rose 4.59%, or 81 cents, to $8.47 in premarket trading Tuesday.

ConAgra Foods (CAG) reported fiscal second-quarter earnings in line with analyst estimates of 45 cents a share, down from 52 cents a share a year earlier.

Shares of the packaged food company fell 0.49%, or 11 cents, to $22.33 in premarket trading.

TD Bank said Tuesday it agreed to buy Chrysler Financial from private-equity firm Cerberus Capital for $6.3 billion in cash.

Shares of TD were down 0.26%, or 18 cents, to $69.33 in premarket trading.

Darden Restaurants (DRI), the company that operates Red Lobster, Olive Garden and LongHorn Steakhouse, posted an in-line profit from continuing operations of $75.8 million, or 54 cents a share, in its latest quarter.

Shares fell in premarket trading to $49, down 2.84%, or $1.43.

Nike (NKE) is set to release its second-quarter earnings after the market closes Tuesday. Analysts polled by Thomson Reuters expect earnings to come in at 88 cents a share, up from 76 cents a share in the same year-ago period.

Nike shares rose 0.37%, or 33 cents, to $90.60 in premarket trading.

Dutch chemicals company DSM offered to acquire Martek Biosciences (MATK) for $31.50 a share, or $1.09 billion in cash. The board of Martek, a biotechnology company, has recommended that shareholders approve the offer.

Shares of Martek rose 33.99%, or $7.94, to $31.30 in premarket trading Tuesday.

AstraZeneca (AZN) said Tuesday it will record a fourth-quarter impairment charge of $445 million as it discontinued development of motavizumab for preventing serious respiratory syncytial virus disease.

Shares of the company fell 0.39%, or 18 cents, to $45.77 in premarket trading.

On Monday, Adobe Systems (ADBE) topped Wall Street expectations by reporting adjusted fiscal fourth-quarter earnings of $285.7 million, or 56 cents a share.

Shares of the graphics design and publishing software maker rose 6.79%, or $1.98, to $31.16 in premarket trading Tuesday.

LaserCard (LCRD) agreed to an $80 million buyout by Sweden's Assa Abloy. LaserCard, which makes secure ID cards, expects the acquisition to close during its fiscal fourth quarter.

Shares of LaserCard were up 39.33%, or $1.75, to $6.20 in premarket trading Tuesday.

More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Theresa McCabe in Boston.

>To contact the writer of this article, click here: Theresa McCabe.

>To follow the writer on Twitter, go to @TheresaMcCabe.

>To submit a news tip, send an email to:


Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs